Coastal Infusion Administers Fasenra®

Fasenra (dupilumab) is used to treat eczema (atopic dermatitis), eosinophilic asthma, nasal polyps accompanied by chronic rhinosinusitis (sinus and nasal cavity swelling), eosinophilic esophagitis (EoE), and prurigo nodularis (a skin condition).

Fasenra is an interleukin-4 (IL-4) receptor alpha antagonist that works by blocking the IL-4 receptor site to reduce inflammation that can lead to symptoms of eczema, asthma, nasal polyps.

What It Treats

Fasenra is used to threat severe, eosinophilic asthma.

Prescribed By

Fasenra is most often prescribed by Pulmonologists, Allergists, and Immunologists.

How it’s Administered

Fasenra is administered by subcutaneous injection. Fasenra injections take only a few minutes.

Frequency

Fasenra is generally administered once every four weeks for the first three doses, then once every eight weeks.

Related Drugs

Cinqair, Dupixent, Nucala, Tezspire, Xolair

Additional Resources

• Fasenra Website
• Prescribing Information
• Co-Pay Assistance

The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies